RHÖN-KLINIKUM Aktiengesellschaft/€RHK
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM AG is a German healthcare provider operating five hospital sites: Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen, Universitätsklinikum Marburg (UKGM), and Zentralklinik Bad Berka. The company offers inpatient and outpatient medical services, treating approximately 913,000 patients annually. Headquartered in Bad Neustadt a. d. Saale, Germany, RHÖN-KLINIKUM AG employs over 18,700 individuals. In 2020, Asklepios Kliniken GmbH & Co. KGaA acquired a majority stake in RHÖN-KLINIKUM AG, leading to a strategic partnership while maintaining RHÖN-KLINIKUM AG's independence within the Asklepios group. The company focuses on cross-sector healthcare delivery, digital transformation, and sustainability initiatives, including plans to achieve CO₂-neutrality in Scope 1 and Scope 2 emissions by 2040.
Ticker
€RHK
Sector
Primary listing
XETRA
Employees
18,821
Headquarters
Website
RHK Metrics
BasicAdvanced
€797M
21.07
€0.56
-
€0.10
0.85%
Price and volume
Market cap
€797M
52-week high
€13.30
52-week low
€11.20
Dividend rate
€0.10
Financial strength
Current ratio
2.278
Quick ratio
2.099
Long term debt to equity
8.745
Total debt to equity
11.448
Dividend payout ratio (TTM)
17.78%
Interest coverage (TTM)
13.48%
Profitability
EBITDA (TTM)
104.668
Gross margin (TTM)
10.72%
Net profit margin (TTM)
1.96%
Operating margin (TTM)
2.41%
Effective tax rate (TTM)
22.68%
Revenue per employee (TTM)
€100,000
Management effectiveness
Return on assets (TTM)
1.57%
Return on equity (TTM)
2.99%
Valuation
Price to earnings (TTM)
21.071
Price to revenue (TTM)
0.412
Price to book
0.61
Price to tangible book (TTM)
0.71
Price to free cash flow (TTM)
-99.984
Free cash flow yield (TTM)
-1.00%
Free cash flow per share (TTM)
-0.118
Dividend yield (TTM)
0.85%
Forward dividend yield
0.85%
Growth
Revenue change (TTM)
6.40%
Earnings per share change (TTM)
-19.44%
3-year revenue growth (CAGR)
5.61%
10-year revenue growth (CAGR)
4.39%
3-year earnings per share growth (CAGR)
6.01%
10-year earnings per share growth (CAGR)
-1.17%
10-year dividend per share growth (CAGR)
-18.77%
Bulls say / Bears say
H1 2025 revenues rose 7.5 % to €883.5 million from €775.5 million a year earlier, driven by a 1.8 % increase in patient numbers, underscoring resilient demand for RHÖN’s services (RHÖN-KLINIKUM press release)
Equity ratio remained robust at 71.3 % at end-June 2025, providing strong balance sheet flexibility for further investments and strategic initiatives (RHÖN-KLINIKUM press release)
The ‘RHÖN Campus’ model and ongoing digital transformation, together with a strategic partnership within the Asklepios Group, create opportunities for cost synergies and enhanced care delivery efficiency (Zentralklinik press release)
H1 2025 EBITDA fell to €46.7 million from €49.1 million in H1 2024 as the expiry of legislative energy‐cost reimbursements and rising wage and material expenses compressed operating margins (RHÖN-KLINIKUM press release)
Consolidated profit plunged to €14.7 million in H1 2025 from €20.6 million a year earlier, reflecting higher financing costs amid geopolitical‐driven cost headwinds (RTTNews)
Ongoing German hospital sector reforms and potential legislative changes pose reimbursement and operational risks, adding uncertainty to the company’s outlook (RHÖN-KLINIKUM press release)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for RHÖN-KLINIKUM Aktiengesellschaft stock?
RHÖN-KLINIKUM Aktiengesellschaft (RHK) has a market cap of €797M as of October 30, 2025.
What is the P/E ratio for RHÖN-KLINIKUM Aktiengesellschaft stock?
The price to earnings (P/E) ratio for RHÖN-KLINIKUM Aktiengesellschaft (RHK) stock is 21.07 as of October 30, 2025.
Does RHÖN-KLINIKUM Aktiengesellschaft stock pay dividends?
Yes, the RHÖN-KLINIKUM Aktiengesellschaft (RHK) stock pays dividends to shareholders. As of October 30, 2025, the dividend rate is €0.1 and the yield is 0.85%. RHÖN-KLINIKUM Aktiengesellschaft has a payout ratio of 17.78% on a trailing twelve-month basis.
When is the next RHÖN-KLINIKUM Aktiengesellschaft dividend payment date?
The next RHÖN-KLINIKUM Aktiengesellschaft (RHK) dividend payment date is unconfirmed.
What is the beta indicator for RHÖN-KLINIKUM Aktiengesellschaft?
RHÖN-KLINIKUM Aktiengesellschaft (RHK) does not currently have a Beta indicator.